SRC and breast carcinoma: CXCL13 facilitates breast cancer cell line migratory activity via the nuclear factor kappa-B ligand (RANKL)-Src pathway, which mediates the upregulation of EMT regulators and matrix metalloproteinase-9 (MMP9) [83,130].